Novartis Ag (NVS) Liabilities and Shareholders Equity (2009 - 2026)
Novartis Ag (NVS) recorded Liabilities and Shareholders Equity of $122.03 billion in Q2 2026, up 16.9% from $104.4 billion a year earlier and up 3.0% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Novartis Ag reported Liabilities and Shareholders Equity of $110.95 billion, up 8.5% from FY2024.
- Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of -2.8% (FY2020 to FY2025).
- Across earlier years, Liabilities and Shareholders Equity came in at $102.25 billion in FY2024 (+2.3%), $99.95 billion in FY2023 (-14.9%), $117.45 billion in FY2022 (-10.9%) and $131.8 billion in FY2021 (+3.1%).
- The Q2 2026 figure is the highest quarterly Liabilities and Shareholders Equity since Q2 2022.
- On a year-over-year basis, Liabilities and Shareholders Equity has increased for seven consecutive quarters, with growth averaging 6.9% over the last eight quarters.
- Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 18.6% in Q1 2026, against a decline of 16.0% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $118.53 billion (Q1 2026), $110.95 billion (Q4 2025) and $107.29 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | 27.42 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 122.03 Bn |
| Mar 31, 2026 | 118.53 Bn |
| Dec 31, 2025 | 110.95 Bn |
| Sep 30, 2025 | 107.29 Bn |
| Jun 30, 2025 | 104.40 Bn |
| Mar 31, 2025 | 99.94 Bn |
| Dec 31, 2024 | 102.25 Bn |
| Sep 30, 2024 | 103.52 Bn |
| Jun 30, 2024 | 97.51 Bn |
| Mar 31, 2024 | 94.33 Bn |
| Dec 31, 2023 | 99.95 Bn |
| Sep 30, 2023 | 112.70 Bn |
| Jun 30, 2023 | 110.98 Bn |
| Mar 31, 2023 | 112.24 Bn |
| Dec 31, 2022 | 117.45 Bn |
| Sep 30, 2022 | 118.46 Bn |
| Jun 30, 2022 | 122.91 Bn |
| Mar 31, 2022 | 125.22 Bn |
| Dec 31, 2021 | 131.80 Bn |
| Sep 30, 2021 | 121.21 Bn |
API Access
Novartis Ag Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();